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Abstract In the present study we show the existence of a 
functional nitric oxide synthase (NOS) in rat liver mitochondria. 
The enzyme uses L-arginine (L-arg) to produce nitric oxide (NO) 
and L-citrulline, and is Ca2+-dependent. L-Arg analogues, IV-
monomefhyl-L-arg and A^-nitro-L-arg, inhibit the enzyme, and 
D-arginine is not a substrate for it. We found mitochondrial NOS 
(mtNOS) activity associated with the inner mitochondrial 
membrane but not with the matrix fraction. In intact, 
succinate-energized mitochondria, the enzyme is constitutively 
active and exerts substantial control over mitochondrial respira-
tion and membrane potential. The activity is further stimulated 
when Ca2+ is taken up by mitochondria. We suggest that the 
existence of mtNOS and its Ca2+ dependence are highly relevant 
for mitochondrial functioning. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Nitric oxide (NO, nitrogen monoxide) is a widespread intra-
and intercellular messenger with a broad spectrum of activities 
in the central nervous, cardiovascular, and immune systems 
[1]. The biosynthesis of NO is accomplished by oxidation of a 
terminal guanidino nitrogen of arginine, yielding citrulline as 
a coproduct, and is catalyzed by members of the NO synthase 
(NOS) family [2]. Three distinct isoforms of NOS have been 
identified in mammalian tissues, referred to as endothelial 
NOS (eNOS), neuronal NOS (nNOS), and inducible NOS 
(iNOS) [3], although none of these enzymes has an absolutely 
tissue-specific pattern of expression. The isoforms are present 
in different locations within the cells: nNOS and iNOS are 
cytosolic [4], whereas eNOS has been shown to be membrane-
associated [5-8]. 
Stimulation of soluble guanylyl cyclase accounts for impor-
tant biological responses to NO [1]. Recently it has become 
evident that also mitochondrial activities are strongly affected 
by NO [9-21]. NO is able to bind to cytochrome oxidase and 
thereby to act as an inhibitor of mitochondrial respiration 
[9,11,12,14-20]. As a consequence of cytochrome oxidase in-
hibition, Ca2+ is released from mitochondria [9,10,21] in 
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parallel to their de-energization [9]. The existence of a Ca2+-
dependent mitochondrially located NOS might, therefore, 
have important biological implications. 
Since 1995 contradictory results concerning the possible 
presence of NOS in mitochondria have been published. Im-
munohistochemical studies, using NADPH diaphorase stain-
ing [22,23] and silver-enhanced gold immunolabelling [24], 
provided evidence for the presence of NOS-like proteins in 
several locations within the mitochondria. Co-localization of 
eNOS with succinate dehydrogenase as a mitochondrial 
marker [14] and cross-reaction of mitochondria with antibod-
ies directed against eNOS [22,24] have been reported. 
Although it was clearly shown that eNOS is primarily local-
ized in membranes, previous studies [22,24] have shown eNOS 
staining in several locations, including the membranes, within 
mitochondria. Cross-reaction of mitochondria with nNOS 
antibodies has also been reported [23]. One study [14] reported 
faint NOS activity in a preparation of rat diaphragm muscle 
mitochondria, but did not rule out the presence of non-mito-
chondrial NOS, nor the influence of the urea cycle in citrulline 
formation, which had been used as the indicator of NOS 
activity. 
In the present study we demonstrate, using established 
methods, (i) NOS activity in mitochondria, where it is located 
at the inner membrane, (ii) that mitochondrial NOS (mtNOS) 
activity is substantial and modulated by Ca2+, and (iii) that 
mtNOS continuously controls mitochondrial respiration. 
2. Materials and methods 
2.1. Chemicals 
L-[2,3-3H]Arginine (36.8 Ci/mmol) was obtained from Sigma, L-
[ureido-14C]citrulline (58.8 mCi/mmol) from New England Nuclear. 
Oxyhemoglobin (Hb02) was prepared as described by Di Iorio [25], 
Human recombinant calmodulin was a generous gift of Dr. D. Gue-
rini, Zurich, Switzerland. Recombinant rat brain nNOS was kindly 
provided by Dr. B. Mayer, Graz, Austria. All other chemicals were 
purchased from standard suppliers, and were of the highest purity 
commercially available. Chemicals were prepared fresh. 
2.2. Isolation of mitochondria and their subfractions 
Tightly coupled liver mitochondria were prepared by differential 
centrifugation as described [26]. The protein content was determined 
by the biuret method with bovine serum albumin as standard. Broken 
mitochondria (BM) were prepared from intact mitochondria (IM) 
(60-100 mg/ml) as follows. After a hypoosmolar shock in four times 
the volume of distilled water the mitochondrial suspension was soni-
cated (Sonifier, Branson Sonic Power Co., operated at 150 W and 
50% duty cycle) for 75 s. The protein content was again determined 
and adjusted with buffer to 20-30 mg/ml. The completeness of mem-
brane disruption was verified by the absence of a mitochondrial mem-
brane potential (A1?) and Ca2+ uptake [27]. To obtain mitoplasts 
(MP), mitochondria were treated with 0.12 mg digitonin/mg of mito-
chondrial protein for 15 min at 4°C and washed twice [28]. Submito-
chondrial particles (SMP) were prepared from MP after hypoosmolar 
shock and sonication, as described for BM preparation, followed by 
centrifugation at 9500 Xg for 10 min [26]. The pellet is referred to as 
SMP. The supernatant was then centrifuged at lOOOOOXg for 35 min 
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at 4°C. The supernatant of this ultracentrifugation is referred to as 
matrix fraction. 
2.3. Spectrophotometric determination of NO 
The measurement of NO is based on its reaction with Hb0 2 and the 
subsequent formation of methemoglobin (metHb), as described [29]. 
Measurements were done at 37°C with a Varian CARY spectropho-
tometer at 401 nm. MetHb formation was recorded at various times 
and quantified by calculations based on an extinction coefficient of 49 
m M - 1 c n r 1 for metHb [29]. Addition of mitochondria or mitochon-
drial subtractions (0.03 mg/ml) was taken as time 0. The medium 
contained Hb0 2 (4 |a.M) and NOS substrates as follows: L-arg (1 
mM), CaCl2 (1 mM), NADPH (0.2 mM), FAD (5 uM), FMN (5 
uM), and BH4 (10 uM) in HEPES buffer (0.1 M, pH 7.4). NO can 
rapidly react with superoxide radicals to produce peroxynitrite. Since 
mitochondria are a well known source of oxygen radicals [30], and 
since high activity of mtNOS reported here may lead to substrate and 
cofactor limitation, which in turn will cause simultaneous generation 
of superoxide and NO by NOS [31-33], 1 kU/ml of superoxide dis-
mutase (SOD) [31] was also provided in this assay. The blank cuvette 
contained buffer, Hb0 2 , NOS substrates and SOD. NO formation 
was tested under the same condition using 3 |xg of recombinant rat 
brain NOS, NOS substrates, and 10 ug/ml of calmodulin in the pres-
ence or absence of BM and IM. 
2.4. Citrulline measurement 
Measurements were done as described [34] except for modifications 
in the size and shape of the cation exchange columns. In a final 
volume of 0.1 ml mitochondria or mitochondrial subfractions were 
incubated as follows. For the protein concentration dependence ex-
periments, 0.01-1 mg of mitochondria or mitochondrial subfractions 
were added to the buffer (37°C) containing NOS substrates supple-
mented with L-[3H]arg (30000-50000 cpm), and incubated for 2 min. 
For the time dependence, 1 mg of IM or SMP was added to buffer 
(final volume 0.1 ml, 37°C) containing NOS substrates supplemented 
with L-[3H]arg (30000-50000 cpm), and incubated for various times. 
For the investigation of basal mtNOS activity, mitochondria were 
added to the buffer supplemented only with L-[3H]arg (30000-50000 
cpm) (without NOS substrates), incubated for 2 min, and then ener-
gized with 0.8 mM K+-succinate. For studying the Ca2+ dependence 
of mtNOS, mitochondria were added to the buffer containing 0.8 mM 
K+-succinate and NOS substrates supplemented with L-[3H]arg 
(30000-50000 cpm) as above, except for using varying Ca2+ concen-
trations. 
The reaction was terminated by addition of 1 ml of chilled 20 mM 
sodium acetate buffer (pH 5.0) containing 2 mM EDTA and 1 mM 
unlabeled L-citrulline. For separation of L-[3H]citrulline from 
L-[3H]arg, half of the final volume (550 (il) was put on spin columns 
(Spin Module, Size 100, Bio-101, Vista, CA) filled with 0.3-0.4 ml of 
the cation exchange resin (Dowex 50W, 8% cross-linkage, 200^M)0 
mesh size, Na+ form) [34]. Loaded columns were centrifuged at 
7000 Xg for 2 min and washed with 200 ul of buffer. The total effluent 
was analyzed by liquid scintillation counting. The columns and the 
resin were tested with both L-[3H]arg and L-[ureido-14C]citrulline for 
their efficiency. 
2.5. Oxygen consumption measurement 
Oxygen consumption of K+-succinate-energized IM, BM, MP or 
SMP (1 mg protein each) was measured at room temperature with 
continuous stirring in 1.3 ml buffer with a Clarke-type electrode, as 
described [35]. In Fig. 3A-C, mtNOS stimulation or inhibition was 
achieved by the addition of mitochondria or mitochondrial subfrac-
tions to the chamber contained NOS substrates (as mentioned above) 
and/or the inhibitor, and then energized with 2.5 mM K+-succinate 
(arrow). In Fig. 3D, addition of NOS substrates is indicated by the 
triangle. 
2.6. Determination of mitochondrial membrane potential 
A*F of succinate-energized mitochondria (1 mg/ml) was measured in 
an Aminco DW-2A spectrophotometer at 511-533 nm in the presence 
of 10 uM safranin as described [27]. At the end of the measurement, 
the uncoupler, carbonyl cyanide /w-chlorophenylhydrazone (CCCP) (1 
uM), was added to ascertain the validity of the measurement. 
2.7. NOS inhibition 
A^-monomethyl-L-arg ( L - N M M A ) (1-3 mM) and JV'-nitro-L-arg 
P. Ghafourifar, C. RichterlFEBS Letters 418 (1997) 291-296 
(L-NA) (1-5 mM) were used for NOS inhibition. In the spectropho-
tometric assay, the inhibitor was added before NOS substrates. In the 
citrulline and 0 2 consumption measurements, mitochondria or mito-
chondrial subfractions were incubated with the inhibitors for 2-5 min 
prior to the addition of NOS substrates. Incubation with the solvent 
alone served as control. In A¥ measurements, the inhibitor was added 
prior to mitochondria. 
3. Results 
N O is highly unstable in aerobic aqueous solutions. It can 
be quantitatively measured via its reaction with H b 0 2 to form 
metHb, which can be detected as an increase in the optical 
density at 401 nm [29]. As shown in Fig. 1, the production of 
N O measured by this technique was detected after the addi-
tion of BM to N O S substrates. Fig. 1 also shows that 1 m M 
L - N M M A abrogates N O formation. Complete inhibition was 
also achieved with 5 m M L - N A (H = 4). When IM or M P were 
used instead of BM, no N O formation was detectable with 
this assay, ruling out a contaminat ion of our mitochondrial 
preparat ion with non-mitochondrial N O S . The H b 0 2 assay is 
not totally specific for N O , but the presence of relatively high 
amounts of SOD in this assay prevents the possible interac-
tion of H b 0 2 with other reactive oxygen or nitrogen species, 
e.g. superoxide or peroxynitrite. Addition of 3 ug of recombi-
nant rat brain n N O S to the buffer containing N O S substrates 
in the presence or absence of B M or I M resulted in a time-
dependent N O formation (not shown) which was inhibited by 
L - N M M A (3 m M ) or E G T A (5 mM) , but not by the arginase 
inhibitor, L-lysine [36] (1 mM) . 
T o investigate the location of N O S in mitochondria, bo th 
SMP and the matrix fraction were also tested. Fig. 1 shows 
the formation of N O by SMP, which is completely inhibited 
by 1 m M L-NMMA. The same full inhibition was also 
achieved by 3 m M L - N A (not shown). The matrix fraction 
did not show any N O S activity (n - 6). 
In the above-mentioned experiments with BM and SMP, 
omission of Ca 2 + (« = 8), N A D P H (» = 4), BH 4 (n = 4) or 
F M N (n = 4), or replacement of L-arg with its stereo-isomer, 
D-arginine (« = 4), reduced N O formation (10-50% and 5-30% 
of control for BM and SMP, respectively), and addition of 
E G T A (5 m M , n = 4) abrogated it. With less than 300 U SOD/ 
ml N O was hardly detectable. Addition of calmodulin (10 ug/ 
ml) did not increase me tHb formation. In the presence of the 
Time (sec) 
Fig. 1. Time-dependent NO formation in mitochondrial subfractions 
measured spectrophotometricaly. NO formation by BM (□) and 
SMP (o) was measured by following the conversion of Hb0 2 to 
metHb at 401 nm. Inhibition by 1 mM L - N M M A of NO formation 
is shown for BM (■) and SMP (•). Each point represents the 
mean + S.E.M. of eight independent experiments. 
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NO scavenger, carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazo-
line-l-oxyl-3-oxide [37] (0.5 rnM), complete inhibition (« = 4) 
of metHb formation was achieved. 
Another widely used assay for NOS activity is the measure-
ment of L-[3H]citrulline produced from L-[3H]arg. Fig. 2A 
shows that mtNOS activity thus assayed in IM, BM, and 
MP is protein concentration-dependent. Citrulline formation 
is sensitive to L - N A (Fig. 2A, inset) and to L - N M M A (not 
shown). The amount of citrulline produced in 1 min by 1 mg 
of BM (3.8±0.76 nmol) (Fig. 2A) is close to the amount of 
NO measured with BM in the Hb0 2 assay after 1 min 
(3.5 ±0.44 nmol/mg) (see Fig. 1). Citrulline formation by 
both IM and SMP is time-dependent and L-NA-sensitive 
(Fig. 2B). Citrulline production was not inhibited by 1 mM 
L-lysine: 5.2 ±0.76 and 8.7 ±1.05 nmol citrulline/mg/min 
(n = 3) were formed by IM in the absence or presence of L-
lysine, respectively. The sensitivity of citrulline formation to-
wards L - N A and L - N M M A and its insensitivity towards L-
lysine strongly suggest that the detected citrulline was due 
to NOS activity. Heat-treated (80°C, 5 min) IM, BM and 
MP did not form citrulline. No citrulline was formed by the 
matrix fraction. 
i 1 1 1 
0 5 10 15 
Time (min) 
Fig. 2. Mitochondrial protein concentration and time dependence of 
mtNOS. A: Protein concentration-dependent activity of mtNOS in 
BM, IM, and MP determined by measuring the formation of 
L-[3H]citrulline. Inset: Inhibition by L-NA of citrulline formation by 
1 mg of mitochondria or mitochondrial subfractions. B: Time 
course of mtNOS activity in IM (□) and SMP (o), and its inhibi-
tion by L-NA (a, IM; • , SMP). Each bar or point represents the 
mean ± S.E.M. of four to six independent experiments. The units of 
the two vertical axes in A are identical. 
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Fig. 3. Effect of mtNOS on 02 consumption by mitochondria and 
mitochondrial subfractions. Oxygen consumption was induced with 
5 mM K+-succinate (arrow) in 1 mg IM (A), 1 mg frozen/thawed 
(5 cycles) IM (B), and 1 mg SMP (C). Trace a, control 02 con-
sumption; trace b, as trace a, but after mtNOS stimulation as de-
scribed in Section 2; trace c, as trace b, but in the presence of 
L-NMMA; trace d, 02 consumption of mitochondria or mitochon-
drial subfractions in the presence of L-NMMA, without NOS sub-
strates. D is as A, but mtNOS stimulation was achieved by addition 
of NOS substrates at the triangle (trace I). Trace II is as trace I, 
but Ca2+ was omitted from the NOS substrates. Traces are repre-
sentative of four to six independent experiments. 
Inhibition by NO of mitochondrial respiration is well estab-
lished (see [12]). To give further evidence of mtNOS activity 
and to investigate its putative function(s) we therefore meas-
ured mitochondrial respiration under conditions of mtNOS 
stimulation and inhibition. Fig. 3A shows that respiration of 
IM is markedly inhibited when mtNOS is stimulated (trace b 
vs. trace a). This inhibition is partially reversed by 1 mM 
L-NMMA (trace c). The same result was obtained with BM 
or MP (data not shown). In the absence of NOS substrates, 
1 mM L - N M M A caused a slight increase in the O2 consump-
tion rate (Fig. 3A, trace d vs. trace a). This stimulation of 
basal respiration by L - N M M A was more pronounced after 
five cycles of freeze-thawing of IM (Fig. 3B, trace d vs. trace 
a). Fig. 3C shows that 0 2 consumption by SMP is also inhib-
itable by mtNOS stimulation (trace a vs. trace b). This inhib-
ition is largely reversed by 1 mM L - N M M A (trace c). Fig. 3C 
also documents a stimulation by 1 mM L - N M M A of basal 
SMP respiration (in the absence of NOS substrates) (trace d 
vs. trace a). 
As mentioned, the basal succinate-supported O2 consump-
tion of BM was suppressed by mtNOS stimulation. Scaveng-
ing of NO by 30 uM Hb0 2 [19] indeed stimulated this basal 
0 2 consumption 1.35-fold (not shown). Pretreatment of BM 
with L - N M M A (1 mM) abolished the stimulation by Hb0 2 . 
Fig. 3D shows that with succinate-supported respiring IM, 
addition of NOS substrates causes a strong inhibition of 0 2 
consumption (trace I). When NOS substrates were omitted, 
one by one, the same inhibition as trace I was achieved (not 
shown) except when Ca2+ was left out (trace II), which led to 
relief of the inhibition. 
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Fig. 4. Basal mtNOS activity, and its effect on mitochondrial respi-
ration and membrane potential. A: Time course of citrulline forma-
tion by 1 mg succinate (0.8 mM)-energized IM (□), and its inhibi-
tion by 3 mM L-NMMA (■). B: Mitochondrial 02 consumption 
measured in parallel with A. Samples of A were take from the incu-
bation mixture used for 02 consumption measurement. The percent-
age of oxygen remaining was calculated based on the calibration 
with a saturated solution of sodium dithionite. C: Effect of 3 mM 
L-NMMA on A*¥ formation by IM under the same conditions as in 
A. At T , K+-succinate (Succ), and at ▲ uncoupler (CCCP) were 
added. Each point represents the mean ± S.E.M. of four independent 
experiments; the traces are representative of four to six independent 
experiments. 
(3 mM) and L - N A (5 mM, not shown) was observed at all 
Ca2+ concentrations used. 
As shown above, addition of NOS inhibitors increased the 
0 2 consumption by mitochondria. To rule out a possible di-
rect chemical reaction of the inhibitors with 0 2 and to inves-
tigate the contribution to mitochondrial 0 2 consumption by 
mtNOS, we blocked succinate-dependent respiration of IM 
(about 23 nmol of 0 2 consumed per min and mg, see Fig. 
3) with antimycin A and after 2 min added L-NMMA or 
L-NA. No alteration in 0 2 level was recorded before and after 
addition of either NOS inhibitor. These findings rule out their 
direct reaction with 0 2 , and also show that the contribution 
of constitutively active mtNOS to the overall mitochondrial 
0 2 consumption is negligible. 
4. Discussion 
In the present study, using independent and well-established 
methods, we show NOS activity in mitochondria. Mitochon-
drial NOS requires Ca2+ and, in a stereo-selective manner, 
uses L-arginine to produce NO and L-citrulline. The activity 
is time- and protein concentration-dependent, and is blocked 
by the L-arginine analogues L - N M M A and L-NA. The spec-
trophotometric detection of NO requires rupture of the inner 
mitochondrial membrane, whereas with the citrulline assay 
NOS activity is detectable with IM, MP, SMP and BM. Sev-
eral thiol containing compounds, notably glutathione, are 
present in mitochondria [38]. Thiols can trap NO and thereby 
conceivably prevent it from reaching the extramitochondrial 
NO indicator, Hb0 2 . In experiments not reported here, we 
found S-nitroso-glutathione, S-nitroso-cysteine and 5-nitro-
so-cysteine-glycine (K. Do et a l , unpublished observation) 
following mtNOS stimulation in IM. 
A successful spectrophotometric detection of mtNOS-pro-
duced NO required high amounts of SOD. This enzyme low-
ers the steady-state concentration of superoxide, a radical with 
which NO eagerly reacts to form peroxynitrite [39-41]. Super-
oxide is produced by both the mitochondrial respiratory chain 
[30] and, under certain conditions, e.g. substrate and cofactors 
limitation, by NOS [40-42]. It is well known that NADPH is 
present in mitochondria in mM concentrations [42]. The pres-
ence in mitochondria of FAD and FMN as components of 
complexes I and II, respectively, is well established [43]. 
To investigate further the basal mtNOS activity, IM were 
incubated for 2 min with L-[3H]arg (30000-50000 cpm) and 
then energized with succinate. Fig. 4A shows L - N M M A 
(3 mM)-sensitive citrulline formation by these mitochondria. 
The 0 2 consumption measurement (Fig. 4B) performed under 
the same condition revealed a parallel increase in 0 2 con-
sumption upon inhibition of the basal mtNOS activity. The 
measurement of A*F (Fig. 4C) performed under the same con-
ditions shows that L - N M M A is able to stimulate both the rate 
and magnitude of AT formation. L - N M M A added to already 
K+-succinate (0.8 mM)-energized mitochondria caused an im-
mediate rise in AT (not shown). 
To give further evidence for the Ca2+ dependence of 
mtNOS, we measured citrulline formation in energized IM in 
the presence of varying amounts of Ca2+ (Fig. 5). The activity 
of the enzyme increases over its basal activity in a Ca2+-
dependent manner. A full inhibition by both L-NMMA 
C a 2 + added (nmol/mg) 
Fig. 5. Calcium dependence of mtNOS activity. Citrulline formation 
by stimulated mtNOS was measured during 5 min with 1 mg K+-
succinate (0.8 mM)-energized IM, in the presence of various Ca2+ 
concentrations, and inhibited by 3 mM L-NMMA. Each point rep-
resents the mean ± S.E.M. of four independent experiments. 
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Although there is some evidence for BH4 [44] in and arginine 
uptake by mitochondria [45] the availability of sufficient 
amounts of these substrates for mtNOS is currently not clear. 
Xia and Zweier [33] reported a pathway for L - N M M A - and 
SOD-sensitive superoxide and peroxynitrite generation from 
iNOS in macrophages depleted of cytosolic L-arginine. Evi-
dence was also presented for nitration of mitochondrial 
MnSOD by peroxynitrite [46], and we found an increase in 
nitrotyrosine level in mitochondria following mtNOS activa-
tion (M. Shigenaga et al., unpublished observation). Peroxy-
nitrite formation, as a possible consequence of L-arginine and/ 
or BH4 limitation for mtNOS activity, of superoxide forma-
tion by respiratory chain, and of mitochondrial SOD activity, 
clearly needs to be investigated further. 
NOS activity in mitochondria was also shown by measuring 
citrulline. Treatment of mitochondria with digitonin during 
MP, and thereby SMP preparations, resulted in increased cit-
rulline formation, compared with IM, presumably because 
this treatment makes the substrates more easily accessible to 
mtNOS. Digitonin treatment solubilizes all but the inner mi-
tochondrial membranes. The fact that MP and SMP were 
separated by centrifugation of washed material rules out a 
possible contribution of non-mitochondrial NOS to the activ-
ity found in MP and SMP. Inhibition by NOS inhibitors of 
citrulline formation was pronounced and most effective in BM 
and SMP, followed by MP and IM. This rank order most 
likely is due to a resistance of the inner mitochondrial mem-
brane to penetration of the inhibitors. 
Immunocytochemical studies by others [22,24] have sug-
gested that mtNOS is located at the cristae, the inner, and 
the outer mitochondrial membrane. Some of the antibodies 
used in those studies were directed against diaphorases. Since 
several such enzymes are present in mitochondria [47], there is 
no consensus that such staining may be valuable for NOS 
detection in mitochondria [22]. Therefore, the immunochem-
ical characterization of NOS in mitochondria requires some 
refinement. 
We show that mitochondrial O2 consumption is suppressed, 
in an L-NMMA-reversible manner, following mtNOS stimu-
lation. This is consistent with the inhibition of mitochondrial 
respiration by exogenous (non-mitochondrial) NO [10-12,15-
20]. Furthermore, we found that L - N M M A stimulates basal 
mitochondrial respiration, in parallel decreases basal citrulline 
formation, and increases A*P. These new findings give further 
evidence for the presence of a functional NOS in mitochon-
dria and, importantly, also suggest that mtNOS is a regulator 
of mitochondrial O2 consumption. The close proximity of 
mtNOS, reported here, to the complexes of the mitochondrial 
electron transport chain appears to allow an efficient control 
of oxidative phosphorylation by mtNOS. 
All types of constitutive NOS investigated so far require 
calmodulin for activity. Whether this is also the case for 
mtNOS is currently unclear. Addition of calmodulin to BM 
did not stimulate metHb formation, but mitochondria may 
have their own calmodulin [48]. In the present study Ca2+ 
was the most effective stimulant for mtNOS activation. In 
our preparation, isolated rat liver mitochondria contain about 
3 nmol Ca2+/mg of protein. Since succinate-energized mito-
chondria produced NO without additional supplementation, 
this Ca2+ level seems to be sufficient for the basal mtNOS 
activity. Loading mitochondria with additional Ca2+ further 
stimulated mtNOS activity. Since mitochondria are an impor-
tant cellular Ca2+ buffer, and since Ca2+ handling by mito-
chondria is important for the organelles themselves and for 
cell proliferation, apoptosis and necrosis [49], the possible in-
volvement of mtNOS in these events needs to be investigated. 
Stimulation of mtNOS by Ca2+ uptake is likely to be part 
of a feedback loop which prevents overloading of the organ-
elle with Ca2+ and allows its release with preserved Ay. Thus, 
we have previously shown that peroxynitrite, the stoichiomet-
ric product of the reaction of NO and superoxide, stimulates 
Ca2+ release from intact mitochondria [27]. Our present find-
ings suggest that uptake of Ca2+ by respiring mitochondria 
may lead to increased peroxynitrite formation in mitochon-
dria, which in turn causes Ca2+ release from intact mitochon-
dria via the pyridine nucleotide-dependent pathway [28] fol-
lowed by mtNOS deactivation. In contrast to NO, 
peroxynitrite does not readily inhibit mitochondrial respira-
tion [19]. Mitochondrial superoxide and SOD, by modulating 
the steady-state concentrations of NO and peroxynitrite, may 
therefore have a hitherto undetected impact on mitochondrial 
respiration and respiration-dependent processes, e.g. ATP for-
mation, ion transport and protein import. This, and the pos-
sible derangement of mitochondrial respiration in some path-
ophysiological states such as heart [18] or brain [19] ischemia 
or neurodegenerative diseases [11], in which the inhibition of 
mitochondrial respiration plays a central role, will be the sub-
ject of further investigations. 
Acknowledgements: This work was supported by the Schweizerische 
Nationalfonds, Grant 31-45821.95. We are indebted to Bernd Mayer 
for providing recombinant rat brain nNOS and for pertinent com-
ments, and thank Sabine D. Klein for technical advice, Renato Laf-
franchi and Matthias Schweizer for critically reading the manuscript, 
and Kaspar H. Winterhalter for his interest and support. 
References 
[1] Moncada, S., Palmer, R.M.J. and Higgs, E.A. (1991) Pharmacol. 
Rev. 43, 109-142. 
[2] Griffith, O.W. and Stuehr, D.J. (1995) Annu. Rev. Physiol. 57, 
707-736. 
[3] Venema, R.C., Ju, H., Zou, R., Ryan, J.W. and Venema, V.J. 
(1997) J. Biol. Chem. 272, 1276-1282. 
[4] Marietta, M.A. (1994) Cell 78, 927-930. 
[5] Busconi, L. and Michel, T. (1993) J. Biol. Chem. 268, 8410-8413. 
[6] Michel, T., Li, G.K. and Busconi, L. (1993) Proc. Natl. Acad. 
Sci. USA 90, 6252-6256. 
[7] Sessa, W.C, Harrison, J.K., Barber, CM., Zeng, D., Durieux, 
M.E., D'Angelo, D.D., Lynch, K.R. and Peach, M.J. (1992) 
J. Biol. Chem. 267, 15274-15276. 
[8] Sessa, W.C., Barber, CM. and Lynch, K.R. (1993) Circ. Res. 72, 
921-924. 
[9] Schweizer, M. and Richter, C. (1994) Biochem. Biophys. Res. 
Commun. 204, 169-175. 
[10] Richter, C, Gogvadze, V., Schlapbach, R., Schweizer, M. and 
Schlegel, J. (1994) Biochem. Biophys. Res. Commun. 205, 1143-
1150. 
[11] Cleeter, M.W.J., Cooper, J.M., Darley-Usmar, V.M., Moncada, 
S. and Schapira, A.H.V. (1994) FEBS Lett. 345, 50-54. 
[12] Brown, G.C (1995) FEBS Lett. 369, 136-139. 
[13] Oddis, C.V. and Finkel, M.S. (1995) Biochem. Biophys. Res. 
Commun. 213, 1002-1009. 
[14] Kobzik, L., Stringer, B., Balligand, J.L., Reid, M.B. and Stamler, 
J.S. (1995) Biochem. Biophys. Res. Commun. 211, 375-381. 
[15] Borutaite, V. and Brown, G.C. (1996) Biochem. J. 315, 295-299. 
[16] Welter, R., Yu, L. and Yu, CA. (1996) Arch. Biochem. Biophys. 
331, 9-14. 
[17] Poderoso, J.J., Carreras, M.C, Lisdero, C, Riobo, N., Schopfer, 
F. and Boveris, A. (1996) Arch. Biochem. Biophys. 328, 85-92. 
[18] Xie, Y.W. and Wolin, M.S. (1996) Circulation 94, 2580-2586. 
296 P. Ghafourifar, C. Richter I FEBS Letters 418 (1997) 291-296 
[19] Lizasoain, I., Moro, M.A., Knowles, R.G., Darley-Usmar, V. 
and Moncada, S. (1996) Biochem. J. 314, 877-880. 
[20] Cassina, A. and Radi, R. (1996) Arch. Biochem. Biophys. 328, 
309-316. 
[21] Laffranchi, R., Gogvadze, V., Richter, C. and Spinas, G.A. 
(1995) Biochem. Biophys. Res. Commun. 217, 584-591. 
[22] Bates, T.E., Loesch, A., Burnstock, G. and Clark, J.B. (1995) 
Biochem. Biophys. Res. Commun. 213, 896-900. 
[23] Frandsen, U., Lopez-Figueroa, M. and Hellsten, Y. (1996) Bio-
chem. Biophys. Res. Commun. 227, 88-93. 
[24] Bates, T.E., Loesch, A., Burnstock, G. and Clark, J.B. (1996) 
Biochem. Biophys. Res. Commun. 218, 40-44. 
[25] Di Iorio, E.E. (1981) Methods Enzymol. 76, 57-72. 
[26] Lotscher, H.R., Winterhalter, K.H., Carafoli, E. and Richter, C. 
(1980) J. Biol. Chem. 225, 9325-9330. 
[27] Schweizer, M. and Richter, C. (1996) Biochemistry 35, 4524-
4528. 
[28] Lotscher, H.R., Winterhalter, K.H., Carafoli, E. and Richter, C. 
(1979) Proc. Natl. Acad. Sci. USA 76, 4340^1344. 
[29] Feelisch, M., Kubitzek, D. and Werringloer, J. (1996) in: Meth-
ods in Nitric Oxide Research (Feelisch, M. and Stamler, J.S., 
Eds.), pp. 455^478, Wiley, Chichester. 
[30] Loschen, G., Azzi, A., Richter, C. and Flohe, L. (1974) FEBS 
Lett. 42, 68-72. 
[31] Mayer, B., Klatt, P., Werner, E.R. and Schmidt, K. (1995) J. Biol. 
Chem. 270, 655-659. 
[32] Pou, S., Pou, W.S., Bredt, D.S., Snyder, S.H. and Rosen, G.M. 
(1992) J. Biol. Chem. 267, 24173-24176. 
[33] Xia, Y. and Zweier, J.L. (1997) Proc. Natl. Acad. Sci. USA 94, 
6954-6958. 
[34] Mayer, B., Klatt, P., Werner, E.R. and Schmidt, K. (1994) Neu-
ropharmacology 33, 1253-1259. 
[35] Frei, B., Winterhalter, K.H. and Richter, C. (1985) J. Biol. 
Chem. 260, 7394-7401. 
[36] Egan, J.M., Henderson, T.E. and Bernier, M. (1995) Am. J. 
Physiol. 269, E61-E66. 
[37] Amano, F. and Noda, T. (1995) FEBS Lett. 368, 425^28. 
[38] Traber, J., Suter, M., Walter, P. and Richter, C. (1992) Biochem. 
Pharmacol. 43, 961-964. 
[39] Schmidt, H.H.H.W., Hofmann, H., Schindler, U., Shutenko, 
Z.S., Cunningham, D.D. and Feelisch, M. (1996) Proc. Natl. 
Acad. Sci. USA 93, 14492-14497. 
[40] Pfeiffer, S., Gorren, A.C.F., Schmidt, K., Werner, E., Hansert, 
B., Scott Bohle, D. and Mayer, B. (1997) J. Biol. Chem. 272, 
3465-3470. 
[41] Pryor, W.A. and Squadrito, G.L. (1995) Am. J. Physiol. 268, 
L699-L722. 
[42] Williamson, J.R. and Corkey, B.E. (1979) Methods Enzymol. 55, 
200-222. 
[43] Darley-Usmar, V., Ragan, I., Smith, P. and Wilson, M. (1994) 
In: Mitochondria: DNA, Proteins and Diseases (Darley-Usmar, 
V. and Schapira, A.H.V., Eds.), pp. 1-25, Portland Press, Lon-
don. 
[44] Rembold, H. and Buff, K. (1972) Eur. J. Biochem. 28, 586-591. 
[45] Freedland, R.A., Grozier, G.L., Hicks, B.L. and Meijer, A.J. 
(1984) Biochim. Biophys. Acta 802, 407-412. 
[46] MacMillan-Crown, L.A., Crow, J.P., Kerby, J.D., Beckman, J.S. 
and Thompson, J.A. (1996) Proc. Natl. Acad. Sci. USA 93, 
11853-11858. 
[47] Frei, B., Winterhalter, K.H. and Richter, C. (1986) Biochemistry 
25, 4438^1443. 
[48] Hatase, O., Tokuda, M., Itano, T., Matsui, H. and Doi, A. 
(1982) Biochem. Biophys. Res. Commun. 104, 673-679. 
[49] Richter, C. (1997) Biosci. Rep. 17, 53-65. 
